Cite

    Takamatsu, H. et al. (n.d.). Changing trends in prognostic factors for patients with multiple myeloma after autologous stem cell transplantation during the immunomodulator drug/proteasome inhibitor era. Cancer science. 106 (2), pp. 179-185. [Online].